Rafferty Asset Management, LLC Corcept Therapeutics Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 11,512 shares of CORT stock, worth $662,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,512

Previous 11,443 0.6%

Holding current value

$662,400

Previous $371,000 43.4%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$29.51 - $46.26 $2,036 - $3,191	69 Added 0.6%	11,512 $532,000
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $91,438 - $141,954	-4,117 Reduced 26.46%	11,443 $371,000
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $150,886 - $196,366	7,151 Added 85.04%	15,560 $391,000
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $208,711 - $276,487	8,409 New	8,409 $273,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $60,119 - $70,878	-2,434 Reduced 21.99%	8,637 $221,000
Q2 2022 Aug 12, 2022	BUY	$17.33 - $25.3 $191,860 - $280,096	11,071 New	11,071 $263,000
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $180,391 - $275,116	-10,913 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $186,612 - $254,709	10,913 New	10,913 $216,000
Q1 2021 May 10, 2021	SELL	$23.49 - $30.56 $237,483 - $308,961	-10,110 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$16.78 - $27.3 $169,645 - $276,003	10,110 New	10,110 $264,000
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $151,825 - $243,456	-12,185 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$11.0 - $18.26 $134,035 - $222,498	12,185 New	12,185 $205,000
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $266,162 - $374,826	-25,568 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$9.78 - $12.76 $227,257 - $296,504	-23,237 Reduced 47.61%	25,568 $285,000
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $489,514 - $766,726	48,805 New	48,805 $573,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $905,775 - $1.17 Million	-59,201 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $863,742 - $1.51 Million	59,201 New	59,201 $974,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Corcept Therapeutics Inc Transaction History